Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Naturhouse Health's gross profit for the
six
months ended in Dec. 2025 was €15.09 Mil. Naturhouse Health's gross profit for the trailing twelve months (TTM) ended in Dec. 2025 was €34.27 Mil.
Naturhouse Health (XMAD:NTH) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Naturhouse Health had a gross margin of 70.96% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Naturhouse Health Gross Profit Related Terms
Naturhouse Health Gross Profit Historical Data
* Premium members only.
The historical data trend for Naturhouse Health's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:NTH vs KHC, GIS, HRL: Gross Profit Comparison
For the Packaged Foods subindustry, Naturhouse Health's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturhouse Health Gross Profit vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's Gross Profit distribution charts can be found below:
* The bar in red indicates where Naturhouse Health's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €34.27 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Naturhouse Health (XMAD:NTH) has a Gross Profit of €34.27 Mil as of Dec. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on Naturhouse Health and its competitors.
Is Naturhouse Health's Gross Profit too high?
Naturhouse Health's current Gross Profit is €34.27 Mil. Overall, Naturhouse Health has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's Gross Profit compare to KHC and GIS?
Naturhouse Health's Gross Profit of €34.27 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Consumer Packaged Goods company?
A good Gross Profit depends on the Consumer Packaged Goods industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Naturhouse Health and its competitors. Naturhouse Health's current Gross Profit is €34.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.61, compared to a current price of €2.56 — trading 59% above its estimated fair value. The current Gross Profit is €34.27 Mil. Naturhouse Health's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current Gross Profit is €34.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?
Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued.
The current stock price of €2.56 is trading 59% above its estimated GF Value™ of €1.61.
GuruFocus considers Naturhouse Health to be Significantly Overvalued.
Key valuation signals for XMAD:NTH:
Gross Profit: €34.27 Mil
GF Value™: €1.61 vs. price of €2.56 (59% above fair value)
No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
79GF Score
Get the complete analysis for XMAD:NTH
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:NTH has been successfully added to your 
